Unique epigenomic signatures identify biologically significant subtypes of MDS and predict response to azacytidine [RNA-Seq]
RNA-seq (gene expression) · human · 83 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Myelodysplastic syndromesThis series is part of our curated briefing on it.
- Samples
- 83 samples: 77 × MDS_AZA vs 6 × Healthy_RNAGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE281562_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1184724 and SRA study SRP544454. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 83 samples.
How we read this: 2 replicated groups read from 83 sample titles; they account for 83 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8623477 MDS_AZA_007 MDS_AZA
- GSM8623478 MDS_AZA_015 MDS_AZA
- GSM8623479 MDS_AZA_016 MDS_AZA
- GSM8623480 MDS_AZA_017 MDS_AZA
- GSM8623481 MDS_AZA_002 MDS_AZA
- GSM8623482 MDS_AZA_009 MDS_AZA
- GSM8623483 MDS_AZA_010 MDS_AZA
- GSM8623484 MDS_AZA_013 MDS_AZA
- GSM8623485 MDS_AZA_018 MDS_AZA
- GSM8623486 MDS_AZA_020 MDS_AZA
- GSM8623487 MDS_AZA_021 MDS_AZA
- GSM8623488 MDS_AZA_022 MDS_AZA
- GSM8623489 MDS_AZA_023 MDS_AZA
- GSM8623490 MDS_AZA_024 MDS_AZA
- GSM8623491 MDS_AZA_025 MDS_AZA
- GSM8623492 MDS_AZA_026 MDS_AZA
- GSM8623493 MDS_AZA_028 MDS_AZA
- GSM8623494 MDS_AZA_029 MDS_AZA
- GSM8623495 MDS_AZA_030 MDS_AZA
- GSM8623496 MDS_AZA_031 MDS_AZA
- GSM8623497 MDS_AZA_027 MDS_AZA
- GSM8623498 MDS_AZA_032 MDS_AZA
- GSM8623499 MDS_AZA_034 MDS_AZA
- GSM8623500 MDS_AZA_035 MDS_AZA
- GSM8623501 MDS_AZA_036 MDS_AZA
- GSM8623502 MDS_AZA_037 MDS_AZA
- GSM8623503 MDS_AZA_038 MDS_AZA
- GSM8623504 MDS_AZA_044 MDS_AZA
- GSM8623505 MDS_AZA_045 MDS_AZA
- GSM8623506 MDS_AZA_046 MDS_AZA
- GSM8623507 MDS_AZA_047 MDS_AZA
- GSM8623508 MDS_AZA_050 MDS_AZA
- GSM8623509 MDS_AZA_051 MDS_AZA
- GSM8623510 MDS_AZA_052 MDS_AZA
- GSM8623511 MDS_AZA_053 MDS_AZA
- GSM8623512 MDS_AZA_055 MDS_AZA
- GSM8623513 MDS_AZA_056 MDS_AZA
- GSM8623514 MDS_AZA_057 MDS_AZA
- GSM8623515 MDS_AZA_058 MDS_AZA
- GSM8623516 MDS_AZA_059 MDS_AZA
+ 43 more — browse all 83 samples with per-sample file links →
- GSE272173 Molecular profiling of pre-and post-5-azacytidine myelodysplastic syndrome samples identifies predictors of response 34 samples same disease briefing · shares azacytidine, predict
- GSE264117 Investigating microenvironment in MDS II 503 samples same disease briefing · shares mds
- GSE211032 Expression Analysis (RNA-Seq) of adult Myelodysplastic Syndromes (MDS)/Acute Myeloid Leukemia (AML) with isolated monosomy 7 compared to controls 45 samples same disease briefing · shares mds
- GSE316081 SLF2 and SMC5 dysfunction drives HSC aging and predisposes to MDS, defining a new inherited bone marrow failure syndrome [RNA-seq] 6 samples same disease briefing · shares mds
- GSE288862 ScRNA-Seq of Human MDS and AML Bone Marrow Marrow Microenvironment. 3 samples same disease briefing · shares mds
- GSE284647 The genotype-integrated gene expression profile at the single-cell level of bone marrow CD34-positive hematopoietic stem and progenitor cells (HSPCs) from a patient with myelodysplastic neoplasms (MDS) harboring germline and somatic DDX41 variants. 1 samples same disease briefing · shares mds
- GSE298020 PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease Progression. 493 samples same disease briefing · shares mds
- GSE275000 Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs 104 samples same disease briefing · shares mds
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.